Nanobiotix

YTD

ALL

Why Robinhood?

You can watch Nanobiotix and buy or sell other stocks, ETFs, and their options commission-free!

About NBTX

Nanobiotix SA is a late-stage biotechnology company, which engages in the development of therapeutic approaches to the treatment of cancer. Its technologies include NanoXray that improves the efficacy of radiation therapy against tumor cells.

CEO

Laurent Lévy

CEOLaurent Lévy

Employees

108

Employees108

Headquarters

Paris, Ile-de-France

HeadquartersParis, Ile-de-France

Founded

2003

Founded2003

Employees

108

Employees108

NBTX Key Statistics

Market cap

415.09M

Market cap415.09M

Price-Earnings ratio

-10.57

Price-Earnings ratio-10.57

Dividend yield

—

Dividend yield—

Average volume

21.36K

Average volume21.36K

High today

$9.14

High today$9.14

Low today

$8.48

Low today$8.48

Open price

$9.14

Open price$9.14

Volume

3.21K

Volume3.21K

52 Week high

$10.59

52 Week high$10.59

52 Week low

$2.76

52 Week low$2.76

NBTX News

TipRanks 23h

Nanobiotix to Present at H.C. Wainwright Investment Conference

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to...